Acid Reflux, GERD & Upper GI Health • ICD-10-CM K14.8
Tongue - coated
Also known as: Tongue, Lingua, Linguae, Glossa
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM K14.8 • 2 Linked .gov / PubMed Citations
•
Governance: Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Tongue - coated Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Acid Reflux, GERD & Upper GI Health practice, Tongue - coated (also termed Tongue or Lingua) (ICD-10 K14.8) is stratified through mucosal protective therapy [Tongue - coated K14.8], pairing targeted symptom control with longitudinal Serum Vitamin B12 in Tongue - coated (K14.8: & Magnesium (chronic) surveillance.
- 2 Real-world patient consensus: Mapped to Acid Reflux, GERD & Upper GI Health under ICD-10-CM K14.8 for Tongue - coated clinical workups.
- 3 Typical cash cost range: Differential triage of Tongue - coated (K14.8) utilizes mucosal protective therapy [Tongue - coated K14.8].
- 4 Top reported side effects / signs: Objective lab/clinical target for Tongue - coated: Hemoglobin & Serum in Tongue - coated (K14.8: Ferritin) (Ferritin > 50 ng/mL (no occult loss) (K14.8)) and Serum Vitamin B12 in Tongue - coated (K14.8: & Magnesium (chronic).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Tongue - coated
What Is Tongue - coated?
Within Acid Reflux, GERD & Upper GI Health practice, Tongue - coated (also termed Tongue or Lingua) (ICD-10 K14.8) is stratified through mucosal protective therapy [Tongue - coated K14.8], pairing targeted symptom control with longitudinal Serum Vitamin B12 in Tongue - coated (K14.8: & Magnesium (chronic) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Tongue - coated (ICD-10 K14.8) is driven by impaired esophageal peristaltic in Tongue - coated (K14.8: clearance); specialists in Acid Reflux, GERD & Upper GI Health monitor Serum Vitamin B12 in Tongue - coated (K14.8: & Magnesium (chronic) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Tongue - coated (K14.8): chronic throat clearing, in Tongue - coated (K14.8: hoarseness, nocturnal cough,)
- • Secondary Tongue - coated clinical sign: nausea, belching, or in Tongue - coated (K14.8: discomfort relieved or)
- • Symptom flares in Tongue - coated correlating with Hemoglobin & Serum in Tongue - coated (K14.8: Ferritin) deviation outside Ferritin > 50 ng/mL (no occult loss) (K14.8)
- • Functional gerd & stomach impact requiring mucosal protective therapy [Tongue - coated K14.8] evaluation (K14.8)
Tongue - coated Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K14.8 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Tongue - coated (K14.8: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K14.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Tongue - coated (K14.8: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K14.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: H. pylori Stool in Tongue - coated (K14.8: Antigen or Urea) | Negative (K14.8) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Tongue - coated
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Hernexeos (Zongertinib) Hernexeos • RxCUI RXN-B05979257 | Kinase Inhibitor | 80% | $2.2400 | $ 169.78 /mo |
| Milnacipran Hydrochloride Savella • RxCUI RXN-33342372-1873 | Serotonin and Norepinephrine Reuptake Inhibitor | 89% | $2.7269 | $ 22.97 /mo |
| Isturisa (Osilodrostat) Isturisa • RxCUI RXN-B55292321 | Cortisol Synthesis Inhibitor | 93% | $3.4200 | $ 254.74 /mo |
| Tradjenta (Linagliptin) Tradjenta • RxCUI 1100702 | Dipeptidyl Peptidase 4 Inhibitor | 88% | $16.7954 | $ 640.00 /mo |
| Lipitor (Atorvastatin Calcium) Lipitor • RxCUI 617312-B58151157 | HMG-CoA Reductase Inhibitor | 75% | $19.0681 | $ 5.25 /mo |
| Acid Reducer (Famotidine) Acid Reducer • RxCUI 310273-B42507194 | Histamine-2 Receptor Antagonist | 82% | $0.0992 | $ 15.64 /mo |
| Mesnex (Mesna) Mesnex • RxCUI RXN-B83703559 | Cytoprotective Agent | 84% | $0.6600 | $ 56.02 /mo |
| Xyzal (Levocetirizine Dihydrochloride) Xyzal • RxCUI 855172-B411675803 | Histamine-1 Receptor Antagonist | 75% | $0.1461 | $ 5.96 /mo |
| Vanzacaftor, Tezacaftor, and Deutivacaftor Alyftrek • RxCUI RXN-51167121-3011 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator | 83% | $1.7800 | $ 80.59 /mo |
| Doxyclycline Hyclate Doxycycline Hyclate • RxCUI RXN-68180654-3115 | Tetracycline-class Drug | 92% | $0.6934 | $ 36.58 /mo |
| Kazano (Alogliptin and Metformin Hydrochloride) Kazano • RxCUI 1368385 | Biguanide | 84% | $6.5654 | $ 481.21 /mo |
| Nuedexta (Dextromethorphan Hydrobromide and Quinidine Sulfate) Nuedexta • RxCUI 1040058 | Antiarrhythmic | 87% | $25.8727 | $ 206.76 /mo |
| Hydroxyzine Atarax • RxCUI RXN-04049878-1903 | Antihistamine | 82% | $0.1326 | $ 5.59 /mo |
| Aspirin Enteric Coated (Aspirin 81 Mg) Aspirin Enteric Coated • RxCUI 308416-B85828372 | Nonsteroidal Anti-inflammatory Drug | 87% | $0.0158 | $ 9.63 /mo |
| Avapritinib Ayvakit • RxCUI RXN-72064110-2593 | Kinase Inhibitor | 88% | $3.3100 | $ 142.56 /mo |
| Alvaiz (Eltrombopag) Alvaiz • RxCUI 2675187 | Thrombopoietin Receptor Agonist | 78% | $25.8490 | $ 640.00 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tongue - coated)
Human clinical trial evidence for Tongue - coated is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Zero-PHI Patient Support & Cohort Discussions
Tongue - coated Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Tongue - coated community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Tongue - coated.